Clinical Drug Experience Knowledgebase

Acquired Immunodeficiency Syndrome (Phase 4)

Buruli Ulcer (Phase 3)

Chagas Disease (Phase 4)

Extensively Drug-Resistant Tuberculosis (Phase 3)

Filariasis (Phase 1)

Gonorrhea (Phase 1)

Hepatitis C (Phase 3)

HIV Infections (Phase 4)

HIV Seropositivity (Phase 3)

Immunologic Deficiency Syndromes (Phase 4)

Infections (Phase 3)

Leishmaniasis (Phase 4)

Leishmaniasis, Cutaneous (Phase 3)

Leishmaniasis, Visceral (Phase 4)

Mycetoma (Phase 2)

Neonatal Sepsis (Phase 2)

Parasitic Diseases (Phase 1)

Protozoan Infections (Phase 1)

Recurrence (Phase 3)

Sepsis (Phase 2)

Toxemia (Phase 2)

Trypanosomiasis (Phase 4)

Trypanosomiasis, African (Phase 4)

Tuberculosis (Phase 4)

Tuberculosis, Multidrug-Resistant (Phase 3)

Tuberculosis, Pulmonary (Phase 3)